Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Most women with gestational diabetes do not require insulin while they’re giving birth, Spanish researchers report in the American Journal of Obstetrics and…
NEW YORK (Reuters Health) – In pregnant women with acute trauma, computed tomography accurately identifies placental abruption, Arizona researchers report. Up to 40% of pregnant women with severe…
NEW YORK (Reuters Health) – Percutaneous tibial nerve stimulation is an effective therapy for overactive bladder symptoms, according to a report in the April issue of The Journal…
NEW YORK (Reuters Health) – Breast cancer patients with ATM missense variants who receive radiation therapy appear to be at increased risk for contralateral breast cancer, according to…
NEW YORK (Reuters Health) – With small breast cancers, doing complete axillary dissections only for positive sentinel lymph node biopsies (SNLB) yields the same 10-year survival – roughly…
NEW YORK (Reuters Health) – Injection of Macroplastique (Uroplasty), a urethral bulking agent, can improve female stress urinary incontinence for at least two years, new research shows. Exactly…
NEW YORK (Reuters Health) – Statin use by women cuts their risk of primary cardiovascular disease (CVD) events by roughly a third, which is similar to the risk…
NEW YORK (Reuters Health) – In young women with stage IA1 cervical cancer, a fertility-preserving conization does not reduce survival compared to hysterectomy, researchers report in the March…
NEW YORK (Reuters Health) – Thrombolysis is a must for female stroke patients if they are to achieve the same outcomes as men, according to a March 2nd…
NEW YORK (Reuters Health) – Contralateral prophylactic mastectomy slightly improves breast cancer-specific survival, primarily in young women with early-stage estrogen receptor (ER)-negative disease, new research shows. “The efficacy…
